Abbott (ABT) Q3 Earnings and Revenues Surpass Estimates

Group 1 - Abbott reported quarterly earnings of $1.21 per share, exceeding the Zacks Consensus Estimate of $1.20 per share, and up from $1.14 per share a year ago, representing an earnings surprise of 0.83% [1] - The company achieved revenues of $10.64 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 0.71% and increasing from $10.14 billion year-over-year [1] - Over the last four quarters, Abbott has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [1] Group 2 - The stock's immediate price movement will depend on management's commentary during the earnings call, with Abbott shares having gained about 5.4% year-to-date compared to the S&P 500's 21.9% gain [2] - The current consensus EPS estimate for the upcoming quarter is $1.34 on revenues of $10.87 billion, and for the current fiscal year, it is $4.66 on revenues of $41.77 billion [4] - The Medical - Products industry, to which Abbott belongs, is currently ranked in the top 26% of over 250 Zacks industries, indicating a favorable outlook for the sector [5]